Baxter International Inc. · NYSE:BAX
Baxter International — Baxter's 2022 Investor Conference
19 slides from Baxter International's conference presentation, May 25, 2022
Slide 1: Acute Therapies, Clinical Nutrition & Medication Delivery
ACUTE THERAPIES, CLINICAL NUTRITION & MEDICATION DELIVERY HEATHER KNIGHT President, Acute Therapies, Clinical Nutrition, Medication Delivery, Latin America and Canada
Slide 2: Forward-Looking Statements
Forward-Looking Statements The presentations being made on May 25, 2022 include forward-looking statements concerning Baxter’s financial results, R&D pipeline, including planned product launches (many of which are subject to regulatory approval and may require additional investment) and results of c
Slide 3: Who We Are…
Who We Are… Mission Driven Inventors Market Leader Innovators Acute Therapies Clinical Nutrition Medication Delivery 120
Slide 4: Global Market Overview
Global Market Overview Market Dynamics $1.5B 6% - 7% $1.2B CAGR Opportunities Acute Therapies 2022E 2025E • Increased awareness of blood purification therapies • Patient volume and complexity increasing with aging populations 1% - 2% $4.0B $4.2B CAGR • Focus on device connectivity and communication
Slide 5: Market-Leading Portfolio
Market-Leading Portfolio Acute Therapies Medication Delivery Drive continued growth in CRRT and innovation in organ Personalize therapy & help eliminate preventable harm support therapies to help to improve outcomes Infusion Systems, IV Access & Sets Acute Therapies Medication $0.8B Delivery Novum I
Slide 6: Acute Therapies
Acute Therapies • A global leader in continuous renal replacement therapy • Innovator in blood purification & advanced filtration technologies • Responded to COVID with significant increase in CRRT solution production & four U.S. Emergency Use Authorization products Baxter Confidential — Do not dist
Slide 7: Strategy To Drive Above-Market Growth Of 7% - 8% Through 2025
Strategy To Drive Above-Market Growth Of 7% - 8% Through 2025 Innovation Market Expansion Operational Efficiency Connected Care: Market Development: Drive Efficiencies: • Offer connected portfolio with real- • Increase therapy adoption through • Expand capacity in Americas & APAC time clinical insig
Slide 8: Innovation Pipeline To Drive Improved Patient Outcomes And Workflow Efficiencies
Innovation Pipeline To Drive Improved Patient Outcomes And Workflow Efficiencies Recent Near Term Future Launches Launches Launches PrisMax 2 CRRT machine NephroClear PrisMax 3 simplifying delivery AKI Diagnostic (EMEA) CRRT machine of therapy with Point of care diagnostic predicting optimized for d
Slide 9: Acute Therapies Innovation Spotlight: Next Generation Blood Purification
Acute Therapies Innovation Spotlight: Next Generation Blood Purification Customer Benefits: Personalized Therapies for Patients…Ease of Use for Clinicians… Additional Therapies for Patient Co-morbidities Future State Streamlined Operations Precision Insights Smart Prescriptions Next Generation Advan
Slide 10: Clinical Nutrition
Clinical Nutrition • Comprehensive global portfolio of parenteral nutrition (PN) solutions & devices • A global leader in PN compounding systems and technologies • Original innovator of ready-to-use multi-chamber PN nutrition bags & only ready-to-use 3-chamber bag for neonates & pediatrics in the wo
Slide 11: Strategy To Drive Above-Market Growth Of 4% - 5% Through 2025
Strategy To Drive Above-Market Growth Of 4% - 5% Through 2025 Innovation Market Expansion Operational Efficiency Core Therapies: Market Development: Drive Efficiencies: • Broaden portfolio with essential • Increase therapy adoption in key • Improve product mix with new product launches near-adjacenc
Slide 12: Innovation Pipeline To Drive Improved Patient Outcomes And Workflow Efficiencies
Innovation Pipeline To Drive Improved Patient Outcomes And Workflow Efficiencies Recent Near Term Future Launches Launches Launches Olimel N12 (OUS) High-protein 3CB Compounding Molecules For safer, more efficient pharmacy compounding Finomel (EMEA, ANZ) Multi-Trace-Elements, Peds Formulations 3CB w
Slide 13: Clinical Nutrition Innovation Spotlight: ExactaMix Pro
Clinical Nutrition Innovation Spotlight: ExactaMix Pro Customer Benefits: Increased Reliability & Efficiency…Better User Interface…Improved Service Options Future State New Operating System New User Interface Digi ConnectCore with WiFi connectivity & Intuitive user interface with updated scalable so
Slide 14: Medication Delivery
Medication Delivery • A global leader in IV therapy with 90+ years of expertise • Leading the safe preparation and delivery of medication • Developing ways to personalize delivery of IV therapies with clinical data Baxter Confidential — Do not distribute without prior approval 131 |
Slide 15: Strategy To Drive Above-Market Growth Of 3% - 4% Through 2025
Strategy To Drive Above-Market Growth Of 3% - 4% Through 2025 Innovation Market Expansion Operational Efficiency Connected Care: Market Development: Drive Efficiencies: • Deliver connected portfolio to • Drive adoption of Starling and • Improve profitability through harness the power of infusion dat
Slide 16: Innovation Pipeline To Drive Improved Patient Outcomes And Workflow Efficiencies
Innovation Pipeline To Drive Improved Patient Outcomes And Workflow Efficiencies Recent Near Term Future Launches Launches Launches Novum IQ Infusion Platform Novum IQ LVP & Syringe Infusion Evo IQ LVP & Syringe (International Markets) Platform (Canada / U.S.)1 Smart infusion platform for internatio
Slide 17: Medication Delivery Innovation Spotlight: Novum IQ
Medication Delivery Innovation Spotlight: Novum IQ Customer Benefits: Enabling Workflow Efficiencies…Improving Patient Insights…Enhancing Safety Future State Infusion Platform + Artificial Intelligence Voalte Communication Medication Safety Software Software Novum IQ Infusion Pump Platform1 LVP PCA
Slide 18: Summary
Summary Our Acute Therapies, Clinical Nutrition and Medication Delivery businesses are well positioned to deliver what our customers value most Acute Therapies: Expand treatment possibilities by personalizing therapies for patients and facilitating greater ease of use for clinicians Clinical Nutriti
Slide 19: Baxter 2022 Investor Conference
Baxter 2022 Investor Conference Wigs ee,
Baxter International — Baxter's 2022 Investor Conference on 6ix